0001213900-21-044967.txt : 20210826 0001213900-21-044967.hdr.sgml : 20210826 20210826121746 ACCESSION NUMBER: 0001213900-21-044967 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210826 DATE AS OF CHANGE: 20210826 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IceCure Medical Ltd. CENTRAL INDEX KEY: 0001584371 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-92815 FILM NUMBER: 211210682 BUSINESS ADDRESS: STREET 1: 7 HA'ESHEL ST., POB 3163 CITY: CAESAREA STATE: L3 ZIP: 38900 BUSINESS PHONE: 972-4-6230333 MAIL ADDRESS: STREET 1: 7 HA'ESHEL ST., POB 3163 CITY: CAESAREA STATE: L3 ZIP: 38900 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA CAPITAL ANSTALT CENTRAL INDEX KEY: 0001140358 IRS NUMBER: 000000000 STATE OF INCORPORATION: N2 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: LETTSTRASSE 32 STREET 2: FL-9490 CITY: VADUZ STATE: N2 ZIP: 00000 BUSINESS PHONE: 011-423-2323195 MAIL ADDRESS: STREET 1: LETTSTRASSE 32 STREET 2: FL-9490 CITY: VADUZ STATE: N2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA CAPITAL AKTIENGESELLSCHAFT DATE OF NAME CHANGE: 20010510 SC 13G 1 ea146498-13galpha_icecure.htm SCHEDULE 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(AMENDMENT NO. ___)

 

ICECURE MEDICAL LTD.

 

(Name of Issuer)

  

ORDINARY SHARES, NO PAR VALUE

 

(Title of Class of Securities)

  

 

 

(CUSIP Number)

 

August 26, 2021

 

(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(c)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

(Continued on following page(s)

 

Page 1 of 5 Pages

 

 

 

 

 

 

CUSIP No.   13G Page 2 of 5 Pages

 

1. NAMES OF REPORTING PERSON
  S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
   
  Alpha Capital Anstalt
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
  (a) ☐
  (b) ☐
3.   SEC USE ONLY
   
4. CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Liechtenstein

5. SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 3,062,852 Ordinary Shares (1)
   
6. SHARED VOTING POWER – None
   
7. SOLE DISPOSITIVE POWER – 3,062,852 Ordinary Shares (1)
   
8. SHARED DISPOSITIVE POWER – None
   

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -  
     
  3,062,852 Ordinary Shares (1)  
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  
    ☐
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9  
     
  9.62% (1)  
12. TYPE OF REPORTING PERSON  
     
  CO  

  

(1) Based on 31,821,865 shares outstanding as reported in the Form F-1 filed with the Securities and Exchange Commission on August 9, 2021.

 

 

 

 

CUSIP No.   13G Page 3 of 5 Pages

  

ITEM 1 (a) NAME OF ISSUER: IceCure Medical Ltd., an Israeli corporation

 

ITEM 1 (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

 

7 Ha’Eshel Street, P.O. Box 3163, Caesarea, Israel 3079504

 

ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt

 

ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

 

Lettstrasse 32, FL-9490 Vaduz, Furstentums, Liechtenstein

 

ITEM 2 (c) CITIZENSHIP: Liechtenstein

 

ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Ordinary Shares, no par value

 

ITEM 2 (e) CUSIP NUMBER:

 

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B): Not applicable

 

ITEM 4 OWNERSHIP

 

(a) AMOUNT BENEFICIALLY OWNED: 3,062,852 Ordinary Shares (1)

 

(b) PERCENT OF CLASS: 9.62% (1)

 

(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:

 

(i) SOLE POWER TO VOTE OR DIRECT THE VOTE

 

3,062,852 Ordinary Shares (1)

 

(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE

 

0 Shares

 

(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

 

3,062,852 Ordinary Shares (1)

 

(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

 

0 Shares

 

 

 

 

CUSIP No.   13G Page 4 of 5 Pages

 

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

 

Not applicable

 

ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

 

Not applicable

 

ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

 

Not applicable

 

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP

 

Not applicable

 

ITEM 9 NOTICE OF DISSOLUTION OF GROUP

 

Not applicable

 

 

 

 

CUSIP No.   13G Page 5 of 5 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  August 26, 2021
  (Date)
   
  /s/ Konrad Ackermann
  (Signature)
   
  Konrad Ackermann, Director
  (Name/Title)